Morgan Stanley Maintains Equal-Weight on Ovintiv, Lowers Price Target to $65

Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE: OVV ) with a Equal-Weight and lowers the price target from $68 to $65.